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Introduction
回OStOn University SchooI of Medicine continues to build upon
a strong foundation’adding to an already rich faculty roster
a d expanding its physical plant to accommodate
ever-increasing research and teaching activities and to provide housing
for students. several recent steps have been taken to pave the way for
Still further success: a major appointment in oncoIogy, the creation of
two more endowed chairs′ advances in several key research areas, and
the initiation of several new construction projects to increase space for
research.
It is my pleasure in this Dean′s Report to welcome a new director of
the Hubert H. Humphrey cancer Research center and to announce the
establishment of two new endowed chairs葛One in medical genetics and
One in arthritis. These are the fourth and fifth new endowed chairs we
have created in just three years. In this report, I also introduce several
Other clinical researchers and faculty members whose work and
teaching are developing rapidly in amyloid and fungal disease, and
PreVention・ We also examine several interesting public-health
initiatives′ and news from our veterans Administration affiliates.
Finally′ We look at activities invoIving our BUSM students and honors
for alumni.
パ乙レレ軌
Aram V. Chobanian, M.D.
Appo血的e櫨t:
DougiasV, FaIier, M.D,, Ph,D,,
named director ofthe
口ubertH. Humph「eyCancerResearch Center
回 his spring′ Douglas V・　eXPIoration of how a cell senses andFaller, M.D., Ph.D.,joined our faculty as
director of the Hubert H.
Humphrey Cancer Research
Center, a PrOfessor of medicine and
vice-Chairman of the Division of
Medicine for he皿atoIogy/oncoIogy.
Dr. Faller brings to the cancer
Center and to the School of
Medicine a combination of
expertise in bench science and
Clinical practice. From the
PerSPeCtive of basic scientific
research, Dr. Fa11er′s work
demonstrates a productive diversity
that embraces the study of nomal
Cells, aS Well as tumor ce11s. He has
made important discoveries in two
areas. The first of these concems
the release of tumors from normal
growth constraints and the
resulting replication that occurs
independent of the need for growth
factors; the second finding concems
a cell’s ability to escape immune
surv eillance.
Dr. Faller′s work in
growth-factor production and
utilization by tumor ce11s and by
normal cells has had important
ramifications in aspects of bioIogy
OutSide of cancer. For example, he
determined the molecular
mechanisms by which normal cells
in blood vessels can sense the
OXygen in the blood that flows
through the blood vessels, and
release growth factors that alter the
StruCture Of the blood vessels
themselves. Research in
growth-factor production led to an
responds to signals to grow
PrOVided by other cells. This work
has relevance for heart disease,
sickle-Cell disease and other
COnditions. ”It has shown us," Dr.
Fa11er said, "that one can′t limit
research ab ut cancer ce11s to work
with tumor lls. "
The second important
d scovery concems the escape of
Cells from immune surveillance.
”Some cells are able to escape the
ab li y of the patient′s immune
SyStem tO reCOgnize and destroy
tumor cells before they begin to
grow. It is very clear in most
animals that the immune system is
extrem ly effective in eliminating
tumors,一’he said. "However, SOme
tumo  viruses have evoIved ways of
making the cells that they infect
invisible to immune systems.
Exploring the mechanism by which
th s occurs, We have discovered
that a numb r of tumor viruses
have the ability to tum off a cell′s
OWn tissue-tyPe antigens, Once
this occurs, the host′s immune
SyStem has no way of recognizing
Or interacting with these cells. We
have discovered ways to reactivate
the pression of tissue-tyPe
antigens in infected ce11s to make
them once again susceptible to
surveillanc . ii
Targeting specific proteins
’一We are finally leaming how
OnCOgeneS WOrk, and how genes
t at keep tumors from growing
function, I- Dr. Fa11er continued.
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DouglasV. Faiier, M,D., Ph,D.
”With pharmacoIogists, We are able
to d ign a drug and pick targets in
the ce  that block activation of the
OnCOgene. We finally have the
targets臆SP Cific proteins. In the
P St there were no targets, Only the
Whole cell growing out of control.
All of this has happened relatively
quickly. Discoveries within the
last two years are now gene-
therapy experiments in the
lab ratory. ii
In the clinics, Dr. Faller will
emphasize a high level of
Pat ent-Oriented care. "Cancer care
is normally a complicated and
highly charged issue, fraught with
emotional overtones invoIving
families and a battery of health
PrOfessio als,'一he said. "I want to
Streamline a d simplify the
COntinuum of patient care as much
as possible, SO that it is perceived
by the patient as Ioving and
considerate. That will become
easier as cancer therapy improves.'一
Prevention wi11 assume a high
Priority, tOO′ With increased
emphasis on screening, nOt Only at
the Medical Center but also at
neighborhood health centers ∴一One
Of the most important things we
Can do for the community is to
OncologistMarianne Prout′ M.D.′ an aSSOCiate p「ofesso「of p踊c hea剛, Center, demonstrates head and
neck cance「-SC「eeni=gteChniquesto Schooi ofMedicine students.
PrOmOte PreVention′ " Dr・ Faller TechnoIogy in 1973, With
Said・ "It is easier to prevent most
adult cancers than it is to cure
them・ The most important cancers
in adults are lung′ bowel, breast,
and head and neck cancers. All of
these cancers are completely
Curable′ if detected early," said Dr.
Faller・ '′The Hubert H. Humphrey
Cancer Research center will
increase the availability of cancer
SCreenings and will provide
immediate referrals for patients
Who need primary care. cancer
SCreenmg is not complicated and
need not take long. It can be done
in community health centers, aS
Well as at medical centers.一'
Recipient of numerous awards
Dr. Faller completed his
undergraduate studies at
Massachusetts Institute of
membership in Phi Beta Kappa. He
entered Harvard Medical School and
af er two years retumed to M.I.T.
for predoctoral work in the
labo atory of Nobel laureate David
Baltimore. After receiving his I)h.D.
in 1978, Dr. Faller retumed to
Harvard to complete medical
Studies, and was awarded the M.D.
degree with honors in 1979. After a
residency in intemal medicine at
the univ rsity of Califomia, San
F ancisco, he retumed to Harvard in
1981 as a fellow in hematoIogy/
OnCOIogy at children′s Hospital
Medical Center and the Dana_Farber
Cancer Institute・ Rising quickly
through academic ranks, Dr. Faller
WaS aPPOinted an associate
PrOfessor of pediatrics in 1988.
Dr. Faller has won numerous
awards and honors, including the
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Ama Fuller Award, the American
Cancer Society Senior Faculty
Award, and election to the
American Society for clinical
Investigation. He has been the
recIPient of research grants from
the American Cancer Society, the
National cancer Institute, the
National Heart, Lung and BIood
Institute, and the American Heart
Association.
Two放eW C心airs are endowed
M血nsky is named to genetics professorship
回he endowment of a new
professorship in human
g netics, the fourth such
endowed chair at the SchooI of
Medicine in three years, underscores
the importance of human genetics
in medical practice and research
today. It is my pleasure to
announce that Aubrey Milunsky,
M.D., D.Sc., has been selected as the
first incumbent of the chair.
The SchooI of Medicine
recognized the rapidly developing
field of medical genetics by
establishing the Center for Human
Genetics in 1982, With Dr.
Milunsky as its director. Dr.
Milunsky, a PrOfessor of pediatrics,
obstetrics and gynecoIogy, and
Pathology, is the author of more
than 2OO papers and several books,
including the recent successful book
for the lay public, C五ojces, No亡
C五ances: A放Esse加」a」 G血de to
Yo耽Hered克y仰d Hea克五
The Center for Human
Genetics today provides important
diagnostic and counseling services
for genetic disorders and conducts
epidemioIogical, mOlecular and
biochemical research. A major
recent accomplishment was the
mapping of the gene for sex-1inked
lympho-PrOliferative disease, a fatal
disorder that is due to genetic
susceptibility to the infectious
mononucleosis virus.
During the last decade, genetic
screening has become a standard of
care, and each year the Center
screens tens of thousands of blood
samples for such genetic defects as
spina bifida and Down′s syndrome.
The goal is pI’imary prevention・ An
example of how such screenings
serve this cause was articulated in
Dr. Milunsky′s recent paper
showing that multivitamins and
f lic cid taken during early
pregnancy prevent neural-tube
defects. Scientists at the Center
c rrently are empIoying a new
technoIogy for analyzing genes for
va ious diseases, including cystic
fibrosis. A year ago, it was not
possible to identify routinely
carriers of the gene for cystic
f brosis; tOday the Center provides
carri r-detection tests and prenatal
diagnosis in 24 hours.
The human genome project,
which will map all human genes by
the end of the century, Wi11 have an
enormous impact on medicine,
Since genes and their interaction
回
Aub「ey M血nsky, M.D., D.Sc.
with their environment influence
all diseas . By establishing this
new endowed chair, Boston
University SchooI of Medicine
acknowledges and anticipates the
COntr bution of human genetics to
the practice of medicine and to
improved patient care.
RheumatoIogy chai「 hono「s Cohen’swork
arly in 1991′ We
announ d the
establishment of a new
endowed chair in rheumatoIogy.
T is chair represents the capstone
of 30 years of excellent research,
teaching and clinical work by Alan
S. Coh n, M.D., Who graduated
with the BUSM Class of 1952 and
retumed here in 1960 to form a
core group to study arthritis and
related disorders.
At that time, he was appointed
the first director of the Section of
Arthritis and Connective Tissue
Diseas s at the Evans Memorial
Department of Clinical Research
and Preve tive Medicine of the
University Hospital. Soon
afterwards, Cohen established a
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unit at the Boston City Hospital,
and later at the Boston VA
Hospital. In adddition he created a
r se rch laboratory at the SchooI
of Medicine.
From the original core group
Of investigators working on
arthritis, the Arthritis Center has
emerged as an intemational
leader, With trainees practicing all
over the world. The flowering of
the Arthritis Center has produced
the Health Services Research and
EpidemioIogy Unit, the Amyloid
Center, and a core group working
in immunoIogy.
Dr. Cohen will be named the
first incumbent of this chair.
Membe「s oftheA軸tis Centerinciude′f「om l的Martha Skinner′ M"D"′Ala= Cohen, M.D., RobertSimms, M.D", and RobertMeenan, M.D.
Key Basjc Research
丁he A皿ritis Center-30Years and Growing
回he Arthritis Center at
Boston University SchooI
Of Medicine originated in
1960, When Alan S. Cohen, M.D.,
now the director of the Center and
the conrad wesselhoeft professor of
Medicine, joined the faculty. In
1977, the Center was chosen by the
National Institutes of Health as one
Of 1 5 Multipurpose Arthritis
Centers in the country.
Today, the Arthritis Center
COntinues as one of the SchooI of
Medicine′s major research centers
and its scientists have attained an
intemational reputation for their
WOrk in arthritis research,
treatment and education. Last fall,
the Dutch Rheumatism Society
awarded Dr. Cohen the Jan van
Bremen Gold Medal for his
Pioneering research on amyloidosis,
and Robert Meenan, M.D., a
PrOfessor of medicine and head of
the Arthritis Section, WaS elected
PreSident of the American College
O Rheumatol gy. Dr, Meenan will
direct the amual meeting of this
SOCiety here in Boston next
November.
Landmark research in amyloidosis
Dr" Coh n recognized quite
early that, Of the various connective
tissue disorders, amyloid disease
represen ed an important challenge
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from the perspective of patient care
and research. During the years
Since publication of his seminal
WOrk identifying and characterizing
amyloid fibrils in 1967, Boston
University SchooI of Medicine has
emerged as a center for diagnosis,
r atment and research on
amyloidosis. At one time, this was
CO Sidered a rare disease主t was
believed that a physician might see
One Or tWO CaSeS in a lifetime of
PraCtic . I  is now known that
amyloidosis occurs both as a
SeCOndary consequence of
inflammatory diseases and as a
hereditary disease. In addition,
amyloid deposition in the pancreas
is present in many diabetic
Patients, and amyloid fibrils in the
brain characterize many individuals
With AIzheimer′s disease.
It is now we11 established that
in amyloidosis, large protein
molecules cannot be broken down
by normal enzymatic activity, but
instead, fold over on themselves,
PrOducing distinctive fibrils, Which
are then deposited in various
human organs. Eventually, these
bulky fibrils replace muscle cells in
the heart, kidneys, nerVeS and
brain, effectively shutting down
normal function. Although there is
as yet no cure for amyloidosis,
teams of clinicians and research
scientists in the Arthritis Research
Center in recent years have
PrOduced a remarkable system of
diagnosis and palliative treatment.
Especially noteworthy is their
development of a diagnostic
technique in which aspirated fat
tissue is studied to diagnose the
disorder. This procedure,
developed and refined by the
Arthritis Center during the 1980s,
is far less invasive or painful than
Other existing methods. Samples
arrive regularly from a11 over the
WOrld for analysis, helping
Physicians to make diagnoses
accurately and simply.
New studies on amy10idosis
These researchers are now
CIosing in on understanding the
molecular processes that may well
lead to preventive and therapeutic
measures. For example, Martha
Skinner, M.D., a PrOfessor of
medicine and director of the
amyloid core unit, reCently began a
new study of patients with a
hereditary form of amyloidosis. To
date, Boston University researchers
have identified five of 12 known
mutations that trigger the fairly
Sudden onset of amyloid fibril
PrOduction in affected individuals.
Dr. Skinner is now monitoring
children in families where
inherited amyloidosis is present′ in
order to leam where the disease is
likely to occur∴一By tracking the
PrOPOrtion of normal and mutant
PrOtein in individuals prior to onset
Of the disease,一I reported Dr.
Skinner, "the study will produce a
bette  understanding of what
triggers that proliferation of
extra-Cellular fibrils in affected
Patients. " Another senior member
Of the team working on amyloid′
Tsura obu Shirahama, M.D.,
Ph.D., a r SearCh professor of
edicine, COnCentrateS his work on
Studi  of amyloid enhancing factor
(AEF), an elusive substance that he
nd collaborators in Canada and
Holland believe has a key role in
he app rance of amyloid.
Carmela R. Abraham, Ph.D., an
ssistant research professor of
med cine, has developed a research
PrOgram tO follow up her discovery
Of a protease inhibitor associated
With amyloid disease in the brain.
Finding the inhibitor prompted her
to search for a protease that may be
the target for inhibition and may
CauSe amyloid fibrils to form. she
is now very cIose to identifying the
SPeCific protein-Cleaving enzyme.
’一The moment we find the protease,
We Can design a drug to inhibit it,''
said Dr. Abraham.
In addition to research on
amylo d dis ase, ePidemioIogical
Studies of major forms of arthritis
and musculoskeletal disease are
being conducted at the Arthritis
C nte . David T. Felson, M.D., an
associat  professor of medicine and
Public health, focuses particularly
On OS eO rthritis, OSteOPOrOSis and
hip fracture He has carried out a
number of major studies in
COnjuncti n with the Framingham
Heart Study population. The
fin ings nclude the first clear
vidence th t obesity in early and
middle ages is associated with
later osteoarthritis of the knees,
and important confirmation that
th use of estrogens by women
Plays a major role in reducing the
risk of hip fracture.
Understa ding fungus
atthe moIecuIar ievei
回ungal diseases, OnCe
CunOSities, are
increasingly commo  in
the united States, aS a reSult of an
increased number of patients with
SuPPreSSed immune systems due
to other diseases and treatments.
Amongst ese are AIDS, and such
therapies as anticancer regimens
and treatments associated with
transplantation.
A SchooI of Medicine team
headed by Richard D. Diamond,
M.D., has been a leader in research
aim d at und standing fungal
diseases nd developing more
effective courses for prevention
and trea ment. Dr. Diamond, a
PrOfessor of medicine, has been
recognized intemationally for his
work in this area. He is credited
W th major contributions toward
defining how human white-blood
Cells, Or leukocytes, COmbat
invad ng microorganisms.
Richa「d D. Diamond′ M.D.
丁h「ee ofthe senior 「esearche「s investigating fungal diseases are′ f「om Ieft′ EIizabeth Simons, Ph.D., Alan Sugar, M.D,,
and StuartLevitz′ M"D" Aiso a senior researcherbutnotpictu「ed is Edwin Sma=, M.D,
Foundation for clinicai
research program
The body’s phagocytes,
neutrophils and macrophages
attack most infections by ingesting
the invaders and then killing the
Organisms or at least halting their
growth・ In Dr. Diamond′s early
WOrk, he showed that these
leukocytes could kill fungi even
though these organisms often were
too large to be "swallowed'一
COmPletely by the phagocytes. His
Original observations contributed to
PrOgreSS by many scientists
Studying defense mechanisms
against infections and also served
as the foundation for a clinical
research program at BUSM that
includes several distinguished
SCientists in the Section of
Infectiou  Diseases.
Two facul y members in the
research roup′ Stuart Levitz, M.D・′
and Edwin H. Smail, M.D., both
assistant professors of medicine,
began as fellowship trainees in the
Boston University Inter-Hospital
Combined program in Infectious
Dis ases. Dr. Levitz has described
the way macrophages interact with
CryPtOCOCCuS, a fungus that is a
major cause of illness and death in
Patie t  with AIDS. Dr. Smail has
demonstrated unique mechanisms
by wh ch fungi can modify host
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defenses・ Alan M. Sugar, M.D., an
associate professor of medicine,
recently described a novel
mechanism by which defense
mecha isms can stop the growth of
Certain fungi and prevent infectioI購
even though the organisms remain
alive・ Dr・ Sugar also is a widely
recognized leader in the develop-
ment and evaluation of new
anti-fungal drugs. The research
group has worked cIosely with
SeVeral collaborators in the basic
SCiences, Particularly Elizabeth R.
Simo s, Ph.D., a PrOfessor of
biochemistry, Who brings to the
PrOject her renowned expertise in
the use of fluorescent probes to
define specific aspects of leukocyte
function.
The recent large award of
SuPPOrt by the National Institutes
of Health for this new research
PrOgram reCOgnizes this group’s
SuCCeSSful interdisciplinary use of
State-Of-the-art teChnoIogy in
molecular immunoIogy and
genetics, COmPuterized image
analysis, and analytical
biochemistry.
investigating defense mechanisms
”We are seeing more fungal
infections today,’’according to Dr.
Diamond. "Traditionally, it has
回
been very hard to develop effective
antibiotics, because fungal cells are
cIoser to mammalian cells: It has
been diff c lt to develop drugs that
Selectively will be potent against
fungal infections without producing
tox c effects on immune cells. The
best drug is very toxic.
"At the molecular level, We are
looking at defense mechanisms
responsible for containing these
infections, il continued Dr. Diamond.
"These systems represent a very
useful general model for looking at
how host-defense mechanisms are
m dulated in the course of
infections. There is a delicate
ba anc  betwe n an inflammatory
response that is supposed to be
PrOteCtive and one that is
d trimental.
"We′re asking, ‘What does the
host have to do to prevent the
inf ction from beginning or
PrOgreSSing?’’1 he added. ”By looking
at the biochemistry and genetics of
fungal ce11  and their growth-
CO trOl m chanisms, We Will
id ntify processes in host
responses in a manner that will
allow suppression of unwanted
OutCOmeS Whil  preserving
important ones and stimulating
missing responses. ”
Fo巾yyears iater, Hea巾Study reachestoward 3rd and 4th generations
Or 40 years, the Boston
University Framingham
Heart Study, in
COnjunction with
the National Institutes of
Health, has been studying
and reporting on lifestyle
and physioIogic factors that
relate to the development of
COrOnary heart disease in
men and women. Much of
the original data on the
major risk factors for heart
disease came from this
Study. Because men
generally have heart attacks
SOOner in life than women,
data on the male population
WaS aVailable earlier. Now,
the investigators are
focusing their research on
problems of the elderly and
on heart disease in women.
Heart disease in women
is a serious medical
problem. It has been found
that women ultimately
suffer the same rates of
heart disease as men, but
have approximately a 10-year
delay in its onset. The
Framingham Heart Study has
made and will continue to make
important contributions to our
understanding of heart disease in
R. Curtis E帖son, M.D.
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WOmen, Since it is one of
the few large epidemioIogic
studies that has included
WOmen. Furthermore, aS
the cohort ages, neW
information about
PreVentive measures for
Other problems of the
elderly, including cancer,
arthritis and dementia′ is
becoming available.
Focus on c帥dhood factors
Boston University
investigators also are
beginning to study the
descendants of the original
Participants in the
Framingham Study. Nearly
20 years ago, they began to
examine the second
generation, that is, the
children of members of the
Original cohort that had
been recruited in 1949. In
1987, a neW Study, the
Framingham Children′s Study, WaS
initiated by R" Curtis Ellison,
M.D., a PrOfessor of medicine and
Public health and chief of the
Section of Preventive Medicine and
Epidemiology. The children′s
Study is looking at members of the
third and fourth generations in
Framingham, the grandchildren
and great-grandchildren of the
Original participants. The study is
focusing on factors early in life
(starting at age three or four〉 that
lead some people to develop
healthier lifestyles than others.
"We lmow that many lifestyle
Characteristics are developed early
in life,iI said Dr. Ellison. "We do
not know′ however, if the teenager
Or yOung adult who eats a healthy
diet and is lean and active is that
Way because of an inherited predis-
POSition or from environmental
factors. our studies should help
tell us where we should put our
PreVention dollars; Whether we
Should focus our efforts on
educating parents, On developing
and implementing new schooI
Curricula′ Or On attemPting to have
the characters on saturday moming
television promote a healthier
lifestyle. "
In other studies, Dr. Ellison has
Shown that modifying the sodium
COntent Of foods served to students
Can lead to significant decreases in
blood pressure. "While we should
be educating our young people to
eat a healthier diet′ii said Dr.
E11ison, "we should not overlook
that fact that persuading food
manufacturers to decrease the
amount of sodium and fat in food
PrOducts is another important way
to improve the health of all."
RaIph Hingson, Sc,D,
HeIpingto cu「bthe societaI costs ofd「unk driving
回t the SchooI of Public
Health, an intervention
Study to reduce morta ty
as a result of driving under the
influence of alcohol has met with
cons derable success.
As part of a lO-year reSearCh
PrOgram n traffic safety, Ralph
Hingson, Sc.D・, a PrOfessor of public
health and epidemioIogy, has
helped New England state
govemmen s valuate the effects of
traffi -S f ty legislation and
implem nt preventive strategies.
The program′s findings sparked
the development of community-
based programs to reduce
utomobile fatalities through
exp nded public-aWareneSS and
enforcement campaigns・
Administered by the Massachusetts
Govemor’s Highway safety Bureau,
the "Saving Lives Program" now
OPerateS in six communities across
the Bay State. The program-Which
receives funding from the
Commonwealth Fund, the National
Highway Traffic Safety
Administration, and the National
Insti ute on AIcoholism and
AIc hoI Abuse-is being evaluated
by the SchooI of public Health,
under the direction of Dr.
Hingson. An important aspect of
the valuation process is the
OngOing feedback that is given to
each participating community.
After targeting problem areas, Dr.
Hingson works with community
leaders to create and implement
networks to change community
norms as they influence traffic
Safety. For example, a
”speedwatch" telephone hotline in
Marlborough a11ows citizens to
Call in t e license-Plate numbers
Of speeding vehicles. The Saving
Lives Program follows up with a
Waming to the car owner and
Marlborough police post
additional speeding patroIs at
loca ons cited in the complaints.
So far′ the program has produced
declines in teenage drunk driving
and speeding nd a marked
reduction in fatal crashes.
八尾vvs舟o棚VA a朋Hates
回Or many yearS, Boston
University SchooI of
Medicine h s enjoyed a
strong and mutually beneficial
relationship with the two large
Veterans Administration Medical
Centers in the greater Boston area.
These hospitals, in Bedford, Mass.,
and on Huntington Avenue in
Boston, Offer our students superb
clinical experiences while at the
same time sustaining a cadre of
excellent c inical investigators.
Their strengths in clinical
research, linked with the expertise
in ba ic research here at the
SchooI of Medicine, COntinue to
Win recognition. □
Gene H. Sto=e「man, M,D.
Cente「for agIng Vete「anS
estabIished at Bedford VA
囚few miles north of
Bos on, in Bedford,
Mass., teaChing and
research programs in geriatrics
and long-term Care Were greatly
strengthened last fall when the
f deral Department of veterans
Affairs awarded one of three new
national Centers for Health
Services Research to the Edith
Nourse Rogers Memorial Veterans
Hospital, also known as the
Bedford VA.
The new program, named the
"Center for Health Maintenance of
Aging Veterans, '一brings together
clinical investigators, health
SCientists, and health-
management experts to improve
the effectiveness, efficiency and
quality of care in the rapidly
growing population of aging
veterans. The award
acknowledges the growing role of
the Bedford Veterans Affairs
Medical Center as a center of
geriatric excellence.
For the past decade and more,
the Bedford VA has been one of
the VA′s 12 Geriatric Research
and Education Clinical Centers
(GRECC上The Bedford GRECC
and the Boston University faculty
associated with it have become
well known nationally and inter-
nationally for neurobioIogical
research programs in AIzheimer’s
disease and in rheumatological
diseases. GRECC Clinical
Director Gene H. Stollerman,
M.D., a PrOfessor of medicine, also
will serve as the director of the
Center for Health Maintenance of
Aging Veterans. He formerly
served as one of the VA′s
Distinguished Physicians,
appointed from among the best in
American medicine. Serving with
Dr. Sto11erman as associate
directors will be Donald Kem,
M.D., M.P.H., an aSSistant
PrOfessor of medicine, and Lewis
Kazis, D.Sc., an aSSistant professor
Of public health and an assistant
research professor of medicine.
"Right now,一' said Dr.
Stollerman, ”we are experiencing a
huge expansion of long-term Care
Services for aging veterans with
COmPlex medical and mental
i11nesses. The VA needs to develop
Strategies for providing
COmPrehensive and continuous
Iong-term Care Within realistic
limits of reimbursement. veterans
Cared for by the VA represent a
more functionally impaired
POPulation than their cohorts cared
for in the private sector. The
interaction of physical, mental
and social impairments requires
multidisciplinary health-Care teamS.
”Until recently, health-Services
research was primarily the domain
Of health managers, eCOnOmists and
ad皿inistrators, " he added. "More
recently, Clinicians who can
evaluate quality of care have been
recruited to this field. They have
been trained in biostatistics,
epidemioIogy and behavioral
SCiences. Boston University School
Of Medicine/SchooI of public
Health has been providing
leadership in this endeavor, and
many present and former Boston
University students and faculty are
now members of the Bedford staff
or are active consultants and
collaborators. "
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Gordon L, Snider, M,D.
Boston’s Snide「wins honor
fo「work reIated to emphysema
t the Boston Veterans
Administration Medical
Center, Gordon L. Snider,
M.D., WaS named co-reCipient of
the 1990 Alton Ochsner Award
Relating Smoking to Health. Dr.
Snider, the Maurice B. Strauss
Professor of Medicine, also is chief
of the medical service at the
Boston VA.
Dr. Snider has had a long and
distinguished career that led to
identification of the specific
enzyme responsible for emphysema
and its treat皿ent. His work began
in the 195Os, first in physioIogical
Studies dealing with altered lung
functions in smoking patients with
山喜
mphy ema and in experimental
animal models of the disease. His
later studies focused on enzymatic
biochemical defects of the disease,
demonstr ting that smoking
destroyed the protecting inhibitors
Of the elastase enzyme that
destroy the lung/s elasticity.
The award recently conferred
On Dr. Snider was named in honor
Of the late Dr. Alton Ochsner, One
of the founders of the Ochsner
Medi al Institutes in New
Orleans, La., and the first
Physician to relate cigarette
SmOking to lung cancer.
Stude放tS
Ciinical expe「ience f「omthe onsetof medicai school
圃ithin weeks of
matriculating, BUSM
Students begin leaming
to hone their skills in conducting
patient interviews, a PrOCeSS that
COntinues through their third year
Of study. These interviews with
patients are videotaped, and then
are critiqued in seminars by their
professors and classmates. By the
time they enter clinical clerkships
in the third year, the students have
leamed how to establish contact
with a patient and how to glean
critical bits of information from
verbal reports and physical signs
they observe. For example, many
Students are participating in a
flu場VaCCine program sponsored by
the H me Medical Service for the
elderly and he homeless, This
enables them to perform a valuable
Public service while leaming
Patient care.
IIThis is a great way for
enthusiastic students to get
hands-On eXPerience and to carry
out what many of us feel is a
responsibili y to the community”
said Michelle Greenwald /93. "We
don′  just want to sit here and leam
things…We Wa t tO be active.’’
Taking partin a fiu-VaCCine program sponsored bythe Home Medicai Service giVeS
BUSM students, iike Ervant Nishanian, Pictured above, an OPPOrtunityto interaCtWith
Boston’s eideriyand homeless popuiatiOnS,
Other students delve into the
School′s vibrant research
environment. Leslie Cunningham
and Dennis Crawford, f r example,
each were awarded a 199O-1991
American Heart Association
Medical Student Research
Fellowship based on their previous
l boratory investigations. The
award a11ows the students to take a
year of  from medical school to
conduct research at the School of
Medicine′s Whitaker
Cardiovascular Institute.
Cumingham is investigating
the role of growth factors in
regulating vascular tone, and
Crawford is studying the effects of
hypertension on the gene
expression of growth factors in the
he rt. Crawford recently applied
for and was accepted to the
M.D./Ph.D. Combined Degree
Progra皿.
M.D,/Ph,D. students
The 50 students in the growing
M.D./Ph.D. Combined Degree
Program are drawn from a pooI of
outstanding young scientists from
across the nation. Brad Fenton, for
example, is studying neuronal
transplantation in the Department
Of Anatomy and Neurobiology.
While still in high school, he did
research at the Rockefeller
University that led to the
development of a new noninvasive
test for central nervous system
demyelinating diseases. As an
undergraduate at M.I.T., he
developed and refined an assay to
identify insulin degrading enzyme.
This award-Winning research
PrOVided a strong background in
bioch mical research techniques,
which continue to be applicable to
his present work. Fenton has
developed the fetal septal
Cholinergic transplant
methodoIogy.
SchooI of Medicine Students fo=ow a va「iety of interests through thei「 caree「 as described in this section; from
ieft, (first row) Dennis C「awford, Athena Pennington, (second 「ow) Loretta Jackson, MicheiIe Greenwaid, B「ad Fenton.
Loretta Jackson was accepted
to Boston University SchooI of
Medicine’s Early Medical SchooI
Selection Program when she was a
SOPhomore at Tougaloo Co11ege.
This program makes it possible for
students from a consortium of
historic black co11eges and
universities to take the Boston
University Modular Medical
Integrated Curriculum during their
Senior year in college, and thereby
enter the first year of medical
schooI with more free time for
el ctives and research.
When she was an
undergraduate,丁ackson began
WOrking in a laboratory in the
D partment of Biochemistry. It was
this experience that led her to apply
to the dual-degree program. Having
COmPleted the first two years of
basic scienc , She now is doing
research on the incorporation of
SOluble elastin protein into its
fibrous matrix. She is developing a
SyStem tO teSt mOdified tropoelastin
in a prokaryotic system in order to
define ose elements necessary for
PrOPer fibrogenesis or scar-tissue
formation.
Another outstanding student
fr m Tougaloo College, Athena
Pennington ′94, also entered our
first-year Class in September
through the Early Medical SchooI
Selection Program. Pennington’s
SuPerb achievement in science
helped her to win a full scholarship
while at Tougaloo and a Martin
Luther King, Jr. Fellowship here at
Boston University. In 1988 she was
named a White House Initiative
Scholar.
Student housing so冊on
For a number of years, We have
sought to find the means of
providing housing for medical
Students, and I am happy to
announce that we have come up
with a solution, Construction to
provide some 60 residential units
across the street from the School,
on Harrison Avenue, is beginning
this spring. These will be
well-plamed suites housing
approximately 120 students. The
class entering in the fall of 1992
wi11 be the first group eligible to
apply for space in this new
residential facility. /See
pre」壷血ary ske亡c五Joca亡ed
o扉z2S上de bac女cover.)臆臆臆」
Students participate in a varietyof activities atthe Schooi ofMedicine in additiontothei「 academic pursuits" Pictu「ed inthe top photo′
Arts Day 1991 broughtoutstudents,facuity and sta航0 0bserve wo「ks bytheir co=eagues. The eventwas sponsored and organized by
the StudentComm柾ee on MediCai SchooI Affairs, aiong withthe SchooIs of Medicine and Pubiic Heaith. Shown in the bottom 「ight
photo,the BUSM string ensembie provided a musicai backdrop fo「the viewers. Pictu「ed atthe bottom left, Studentstake
advantage ofa new exe「cise room iocated in the Robinson Bu冊ngthat「ecentiy opened fortheirexciusive use"
AIu棚かI
RegionaI aIumni meetings and aiumni awards
回he opportunity to travel
around the country this
year to mee  with many
Boston University School of
Medicine graduates, leaming about
the practice of medicine in so many
Settings, WaS fascinating and
instructive. I made stops in Lake
Success, N・Y.; Los Angeles, Calif.;
WashiIigton′ D・C.; Miami, Fla弓
Phoenix, Ariz.声nd Puerto Rico. It
WaS an honor in addition, tO have
Louis Sullivan ′58, U・S. Secretary of
Health and Human Services, retum
to give the May 1990 commence-
ment address.
AIumnus hono「ed
Mo面merJ" Buckiey′58 was
honored by the Boston University
General Alumni Association for
distinguished service to the medical
PrOfession. Chief of the Cardiac
Surgical Unit at Massachusetts
General Hospital and a professor of
Surgery at Harvard Medical School,
Dr・ Buckley is a renowned
Cardiovascular surgeon.
While a student here, Dr.
Buckley was elected to the AIpha
Omega AIpha honor society. After
COmpleting his residency at
Massachusetts General Hospital, he
eamed a faculty appointment at
Harvard Medical School in 1960,
and became a fu11 professor of
Surgery in 1977. Among his many
COntributions to surgical technique
and technoIogy has been his work
On the intra-aOrtic balloon pump,
Which has proven to be
indispensable for cardiac surgery.
Dr・ Buckley is chairman of the
Inter-Society Commission for Heart
Disease Resources Cardiac Review
Panel and the American College of
Ca dioIogy cardiovascular Surgery
Council. H  received the Boston
University SchooI of Medicine′s
Distinguished Alumnus Award in
1982.
Distinguished Aiumnus Awards, 1990
The 1990 Distinguished
Alumnus Awards were presented by
then-PreSiden  of the Alumni
Ass cia ion Elizabeth c. Dooling
’65 during the Association′s l 15th
annual meeting and banquet held
On May 12, 1990. Awards were
PreSented to the following:
George D. Maikasian Jr, ’54is
PreSident of the American College
Of Obstetricians and GynecoIogists
and senio  associate consultant to
the Department of Obstetrics and
GynecoIogy at the Mayo Clinic.
He was chaiman of the department
from 1976 to 1986, andis an
authority on gynecoIogic
Chemotherapy.
Ralph C. Marcove ’54 is an
associate attending surgeon at
Memorial sIoan Kettering Cancer
Center and a clinical professor of
Orthopedic surgery at Comell
University Medical School. He has
WOn reCOgnition for his work on
the treatment of bone tumors.
Edward L, Schneider ′66 is a
PrOfessor and dean at Leonard
Davis SchooI of GerontoIogy,
University of Southem califomia,
nd executive director of the Ethel
Percy Andrus GerontoIogy center
at the University of Southem
Califomia・ He served as deputy
director of the National Institute
On Aging at the National Institutes
Of Health from 1985 to 1987.口
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Frankiin G, Ebaugh, Jr.′ M.D,, a former dean of the School of Medicine, died
of cancer on Aug. 7, 1990, at his home in Stanford, Calif. He was 68
years old.
Dr. Ebaugh eamed his medical degree at Comell Medical College in
1946 and worked at the National Institutes of Health, Dartmouth
Medical School and Mary Hitchcock Memorial Hospital before coming to
Boston University. During his tenure as dean from 1965 to 1969, Dr.
Ebaugh was instrumental in developing curricular changes that included
the School′s highly successful Six-Year Program. His vigorous campaign
to modemize the library when the Instructional Building was being built
is legendary.
Upon leaving Boston University, Dr. Ebaugh became dean at the
University of utah Medical School. More recently, he served as associate
dean for veterans affairs and a professor of medicine at Stanford
University Medical School. At the time of his death, he was chief of staff
at the Veterans Affairs Medical Center in Palo Alto, Calif. □
Charies P. Emerson, M,D., PrOfessor emeritus at the SchooI of Medicine and
chief of hematoIogy at the University Hospital, died of a heart attack on
Jan. 23, 1991, at his home in Wellesley, Mass. He was 78 years old・
After graduating from Harvard Medical School in 1937, Dr・ Emerson
served as a lieutenant coIonel in the Army Medical Corps with the Fifth
General Hospital in England and France during World War II. He
received a Bronze Star for developing a more efficient technique of
administering transfusions to wounded soldiers on the battlefield・
In 1947, he came to the Medical School as an assistant professor of
medicine and as director of the blood bank. He was responsible for
bringing the Naval BIood Research Laboratory to the Medical School・ He
and his colleagues were the first to develop techniques to measure blood
volumes and red-Cell survival using radioactive isotopes.
And「ew Dimitri訓a, M.D., a PrOfessor emeritus, died of emphysema on Feb.
5, 1991, at his home in Wellesley Hi11s, Mass. He was 84 years old・ A
1935 graduate of the School of Medicine, Dr. Elia practiced obstetrics at
the Massachusetts Memorial Hospitals, nOW the University Hospital. He
also practiced at the Boston Lying-In Hospital, Which is now part of the
Brigham and Women’s Hospital.
During World War II, Dr. Elia served in the U.S. Navy as the ship’s
doctor aboard the U.S.S. Sa克nas. Reportedly, he was the model for the
doctor in the stage and film versions of '一Mister Roberts.一’
The above a「chitectu「ai rendering ofthe oId Boston Coilege High School on Har「ison Ave…e aCrOSSfromthe Schooi of Medicine
Shows part ofthe structure thatw冊e rehabiiitated to provide approximateIy 60 residentiaI suites for BUSM students.

